Captrust Financial Advisors Ampio Pharmaceuticals, Inc. Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.56 - $1.71 $12,395 - $37,850	-22,135 Reduced 19.67%	90,400 $52,000
Q2 2021 Aug 16, 2021	BUY	$1.56 - $1.98 $858 - $1,089	550 Added 0.49%	112,535 $188,000
Q1 2021 May 17, 2021	BUY	$1.36 - $2.49 $76,275 - $139,651	56,085 Added 100.33%	111,985 $189,000
Q4 2020 Feb 16, 2021	BUY	$0.75 - $2.76 $41,925 - $154,284	55,900 New	55,900 $89,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.